CD19 抗体 (PE)
Quick Overview for CD19 抗体 (PE) (ABIN2704188)
抗原
See all CD19 抗体适用
宿主
克隆类型
标记
应用范围
质量等级
克隆位点
-
-
原理
- CD19 PE Antibody
-
产品特性
- The clone 4G7 recognizes a 90- kDa CD19 antigen that is present on human B lymphocytes. The CD19 antigen is present on approximately 7 to 23 % of human peripheral blood lymphocytes at all stages of B cell maturation but is lost on terminally differentiated plasma cells. CD19 does not react with resting or activated T lymphocytes, granulocytes, or monocytes.
-
纯化方法
- Purified
-
纯度
- >95 %
-
免疫原
- Human CCL (chronic lymphocytic leukemia) cells
-
亚型
- IgG1, kappa
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 25 μg/mL
-
缓冲液
- PBS pH 7.2, 0.2 % (w/v) BSA, 0.09 % (w/v) sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- 2-8°C, Conjugated antibodies should never be frozen.
-
-
- CD19 (CD19 Molecule (CD19))
-
别名
- CD19
-
NCBI登录号
- NM_001770
-
UniProt
- P15391
-
途径
- Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
抗原
-